rs375046805
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_015346.4(ZFYVE26):c.2682G>A(p.Ala894Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000039   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000012   (  0   hom.  ) 
Consequence
 ZFYVE26
NM_015346.4 synonymous
NM_015346.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.420  
Publications
1 publications found 
Genes affected
 ZFYVE26  (HGNC:20761):  (zinc finger FYVE-type containing 26) This gene encodes a protein which contains a FYVE zinc finger binding domain. The presence of this domain is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. [provided by RefSeq, Oct 2008] 
ZFYVE26 Gene-Disease associations (from GenCC):
- hereditary spastic paraplegia 15Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Myriad Women’s Health, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61). 
BP6
Variant 14-67790645-C-T is Benign according to our data. Variant chr14-67790645-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 458280.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-0.42 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000394  AC: 6AN: 152194Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6
AN: 
152194
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000278  AC: 7AN: 251468 AF XY:  0.0000294   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
7
AN: 
251468
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000123  AC: 18AN: 1461830Hom.:  0  Cov.: 32 AF XY:  0.0000110  AC XY: 8AN XY: 727208 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
18
AN: 
1461830
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
8
AN XY: 
727208
show subpopulations 
African (AFR) 
 AF: 
AC: 
6
AN: 
33478
American (AMR) 
 AF: 
AC: 
0
AN: 
44720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86248
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53414
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
11
AN: 
1111978
Other (OTH) 
 AF: 
AC: 
0
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.456 
Heterozygous variant carriers
 0 
 2 
 4 
 5 
 7 
 9 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000394  AC: 6AN: 152312Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74480 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6
AN: 
152312
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2
AN XY: 
74480
show subpopulations 
African (AFR) 
 AF: 
AC: 
6
AN: 
41562
American (AMR) 
 AF: 
AC: 
0
AN: 
15298
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68032
Other (OTH) 
 AF: 
AC: 
0
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.433 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Spastic paraplegia    Benign:1 
Jul 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.